Bayer to invest $10m in Israeli agritech through TrendlinesApr. 21, 2016
The Bayer pharmaceutical company, a global leader in agriculture, has signed an agreement to invest $10 million in agricultural ventures in partnership with Trendlines, an Israeli investment company dealing in medical equipment and agricultural technologies.
Under the agreement, Trendlines will manage the investments in the early stages and raise additional capital for the companies. The joint fund will focus primarily on development of seeds and plant protection, and invest mainly in early stage companies, although it can also consider investments in companies at a later stage. The fund will not invest in Trendlines' existing portfolio.
Trendlines has founded two incubators in Israel: one for medical devices and one for agriculture. Last year, Trendlines held its IPO on the Singapore Stock Exchange, after giving up on its attempt to hold an IPO on a Canadian stock exchange. Trendlines' market cap is $84 million.
For the full Globes news item click here.